EditorialEditorial
CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice
Mengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun and Shanshan Weng
Cancer Biology & Medicine September 2023, 20 (9) 640-645; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0211
Mengyuan Yang
1Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, Chinese National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
Ziheng Xu
1Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, Chinese National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
Mi Mi
1Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, Chinese National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
Yuwei Ding
1Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, Chinese National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
Yuefen Pan
2Department of Medical Oncology, Huzhou Central Hospital, Huzhou 313000, China
Ying Yuan
1Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, Chinese National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
3Zhejiang Provincial Clinical Research Center for Cancer, Hangzhou 310009, China
4Cancer Center of Zhejiang University, Hangzhou 310058, China
5Binjiang Institute of Zhejiang University, Hangzhou 310052, China
Weijing Sun
6Department of Medical Oncology, The University of Kansas, School of Medicine, Lawrence, KS 66045, United States
Shanshan Weng
1Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, Chinese National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
3Zhejiang Provincial Clinical Research Center for Cancer, Hangzhou 310009, China
4Cancer Center of Zhejiang University, Hangzhou 310058, China
5Binjiang Institute of Zhejiang University, Hangzhou 310052, China
References
- 1.↵
- Zheng RS,
- Zhang SW,
- Sun KX,
- Chen R,
- Wang SM,
- Li L, et al.
- 2.↵
- Jiang Y,
- Yuan H,
- Li Z,
- Ji X,
- Shen Q,
- Tuo J, et al.
- 3.↵
- 4.↵
- Yao J,
- Zhen Y,
- Fan J,
- Gong Y,
- Ye Y,
- Guo S, et al.
- 5.↵
- Dong C,
- Ding Y,
- Weng S,
- Li G,
- Huang Y,
- Hu H, et al.
- 6.↵
- Yuan Y,
- Wang X,
- Chen G,
- Wang Y,
- Sheng W,
- Li X, et al.
- 7.↵
- Weng S,
- Yuan Y,
- Wang X,
- Chen G,
- Wang Y,
- Sheng W, et al.
- 8.
- Yuan Z,
- Weng S,
- Ye C,
- Hu H,
- Zhang S,
- Yuan Y.
- 9.↵
- Mi M,
- Weng S,
- Xu Z,
- Hu H,
- Wang Y,
- Yuan Y, et al.
- 10.↵
- Kopetz S,
- Desai J,
- Chan E,
- Hecht JR,
- O’Dwyer PJ,
- Maru D, et al.
- 11.↵
- Yang H,
- Higgins B,
- Kolinsky K,
- Packman K,
- Bradley WD,
- Lee RJ, et al.
- 12.↵
- Corcoran RB,
- Atreya CE,
- Falchook GS,
- Kwak EL,
- Ryan DP,
- Bendell JC, et al.
- 13.↵
- Ross JS,
- Ali SM,
- Elvin JA,
- Schrock AB,
- Suh J,
- Vergilio J-A, et al.
- 14.↵
- Sartore-Bianchi A,
- Trusolino L,
- Martino C,
- Bencardino K,
- Lonardi S,
- Bergamo F, et al.
- 15.↵
- 16.↵
- Nassar AH,
- Adib E,
- Kwiatkowski DJ.
- 17.↵
- 18.↵
- 19.↵
In this issue
CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice
Mengyuan Yang, Ziheng Xu, Mi Mi, Yuwei Ding, Yuefen Pan, Ying Yuan, Weijing Sun, Shanshan Weng
Cancer Biology & Medicine Sep 2023, 20 (9) 640-645; DOI: 10.20892/j.issn.2095-3941.2023.0211
Jump to section
- Article
- Treatment of mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) mCRC
- Treatment of mCRC with a BRAF V600E mutation
- Treatment of mCRC with HER-2 amplification
- Treatment of mCRC with a KRAS G12C mutation
- Treatment of mCRC with NTRK gene fusion
- Conclusions and insights
- Conflict of interest statement
- Author contributions
- Acknowledgements
- Footnotes
- References
- Figures & Data
- References
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- No citing articles found.